Literature DB >> 19021197

Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features.

Guo-Zhao Meng1, Hong-Ying Zhang, Hong Bu, Jian-Guo Geng.   

Abstract

We have studied 11 cases of low-grade fibromyxoid sarcoma (LGFMS) and 15 cases of fibromatosis with respect to clinicopathological features and immunohistochemical expression of Ki-67, nm23, cyclinD1, and p53, in order to investigate the differential diagnosis between this two groups. Formalin-fixed, paraffin-embedded sections from 11 cases of LGFMS and 15 cases of fibromatosis were studied histologically and immunohistochemically. The immunostainings were semiquantitatively evaluated using the Allred score system. Microscopically, LGFMS was composed of bland spindle cells arranged in a whorled pattern showing alternating myxoid zones and fibrous stroma zones with prominent arcade curvilinear capillaries. Cytological atypia, mitotic figures, and tumor necrosis were absent in all 11 cases of LGFMS. In contrast, fibromatosis was less cellular and more fascicular, containing more collagen and showing no alternating fibrous and myxoid zones as compared with LGFMS. The immunostaining scores of nm23 in LGFMS were significantly lower than that in fibromatosis. The immunostaining scores of Ki-67, p53, and cyclinD1 in LGFMS were significantly higher than that in fibromatosis. Thus, we consider that LGFMS can be distinguished from fibromatosis by clinicopathological features, and assessments of the immunohistochemical expression level of cyclinD1, p53, nm23, and Ki-67 are helpful in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19021197     DOI: 10.1002/dc.20967

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  1 in total

1.  Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases.

Authors:  Mengtian Li; Huijiao Chen; Dengchao Shi; Min Chen; Zhang Zhang; Hongying Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.